CHRND: A Protein Target for Cancer, Neurodegenerative Diseases and Autoimmune Disorders

Target Name: CHRND

NCBI ID: G1144

CHRND

CHRND: A Protein Target for Cancer, Neurodegenerative Diseases and Autoimmune Disorders

CHRND (CHRNA-N-D) is a drug target (or biomarker) that has been shown to have a significant impact on various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. CHRND is a protein that is expressed in various tissues and cells in the body, including the brain, and is involved in a number of different cellular processes.

One of the key functions of CHRND is its role in the development and progression of cancer. Many studies have shown that high levels of CHRND are associated with an increased risk of cancer, and that inhibiting the activity of CHRND may be a useful strategy for treating cancer. One of the reasons for this is that CHRND has been shown to promote the growth and survival of cancer cells, and it is possible that inhibiting its activity may disrupt these processes.

Another area where CHRND has been shown to be involved in the development and progression of neurodegenerative diseases is in the development of Alzheimer's disease. CHRND has been shown to be involved in the production of neurodegeneration, and may be a potential drug target for treatments of this disease.

CHRND has also been shown to be involved in the development and progression of autoimmune disorders, such as rheumatoid arthritis and multiple sclerosis. In these diseases, the immune system mistakenly attacks healthy cells and tissues, leading to inflammation and pain. CHRND has been shown to be involved in the regulation of immune responses, and may be a potential drug target for treating these disorders.

In addition to its potential as a drug target, CHRND has also been shown to have a number of potential therapeutic applications in other areas. For example, CHRND has been shown to be involved in the regulation of pain, and may be a potential drug target for treating chronic pain. It has also been shown to be involved in the regulation of mood and emotion, and may be a potential drug target for treating mood disorders and anxiety.

Overall, CHRND is a protein that has been shown to be involved in a number of different cellular processes in the body. Its potential as a drug target makes it an attractive target for researchers to investigate further, and may lead to new treatments for a variety of diseases.

Protein Name: Cholinergic Receptor Nicotinic Delta Subunit

Functions: After binding acetylcholine, the AChR responds by an extensive change in conformation that affects all subunits and leads to opening of an ion-conducting channel across the plasma membrane

The "CHRND Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CHRND comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets